newsfilter
← Latest News
GlobeNewswire·

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

  • Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) announced that Founder, President, & CEO Laxminarayan Bhat, Ph.D. will present at the Sachs 9th Annual Neuroscience Innovation Forum.
  • The presentation is scheduled for Sunday, January 11, 2026, at 1:20 PM PT at the Marines' Memorial Club in San Francisco, CA.
  • Reviva is a late-stage biopharmaceutical company developing next-generation therapeutics for central nervous system (CNS), inflammatory, & cardiometabolic diseases.
  • The company's pipeline includes two in-house discovered new chemical entities: brilaroxazine (RP5063) & RP1208.
  • Reviva holds composition of matter patents for both brilaroxazine & RP1208 in the United States, Europe, & several other countries.